Donate Eggs, Freeze Yours Free: A New Fertility Frontier

SCOTTSDALE, Ariz. – March 06, 2026 – A leading U.S. cryobank has unveiled a novel program that could reshape the landscape of egg donation and fertility preservation. The World Egg and Sperm Bank (TWESB) today launched “Give & Receive,” an initiative that allows women to donate eggs to help others build a family, and in return, freeze a batch of their own eggs for future use—all at no cost.

The program is being positioned as a revolutionary step in empowering young adults with reproductive choice. “We created the Give & Receive program with empowerment, choice and future planning in mind,” said TWESB CEO Diana Thomas in a statement. “By participating, young adults are helping create families today while preserving options for their own tomorrow.”

While the announcement highlights a blend of altruism and personal benefit, the new model arrives amidst a booming, multi-billion-dollar fertility industry and raises complex questions about market dynamics, donor motivation, and the ethical boundaries of reproductive medicine.

A Fertility Safety Net in a High-Cost Market

The core promise of the “Give & Receive” program is access. Elective egg freezing, a procedure that has nearly quadrupled in the U.S. since 2014, offers women a chance to pause their biological clock, but it comes with a hefty price tag, often ranging from $10,000 to $40,000 for a single cycle, plus annual storage fees. This cost has historically placed it out of reach for many.

TWESB’s program dismantles this financial barrier for its participants. After completing an initial donation cycle, eligible donors can enter the “Give & Receive” track. During their next donation, 12 of their retrieved eggs are frozen and reserved for their own personal use. The program also offers the option of a third donation, which could yield up to another 12 frozen eggs for the donor.

Participants also receive comprehensive fertility testing and genetic screening results, providing valuable health insights they can use for their own future family planning. This dual-benefit model frames egg donation not just as an act of altruism but as a strategic personal health decision—a “fertility safety net,” as the company describes it.

“At a time when birthrates are declining and many face limited reproductive options, the Give and Receive egg-banking program offers an extraordinary way to empower individuals while supporting others in their journey to parenthood,” Thomas added.

Disrupting the Donor Market

While TWESB, founded in 2004 as a pioneer independent egg bank, is promoting its program as an innovation, it enters an emerging market niche. Other organizations, such as Cofertility and MyEggBank, have already introduced similar “egg sharing” or “freeze and donate” models. Cofertility’s “Split” program, for example, allows a woman to freeze her eggs for free if she donates half of the retrieved eggs to an intended parent, who covers all medical and storage costs.

These programs are a strategic response to powerful market forces. The global fertility services market is projected to grow exponentially, potentially exceeding $150 billion by 2034. This growth is fueled by rising infertility rates, an increase in single-parent and LGBTQ+ family building, and a cultural shift toward delaying parenthood for personal or professional reasons.

At the same time, the demand for donor eggs has surged, with some industry reports showing a nearly 50% increase in requests over the past five years. By bundling donation with the highly desirable perk of free egg freezing, banks like TWESB can attract a new demographic of donors, potentially expanding the limited supply of available eggs. This could be a significant competitive advantage in a crowded market, altering the economic calculus for both donors and recipients.

The Ethical Crossroads of Compensation

As these dual-benefit models gain traction, they are drawing scrutiny from bioethicists and reproductive health advocates. The central ethical dilemma revolves around the concept of undue inducement. Critics question whether an offer valued at tens of thousands of dollars could pressure women, particularly those with fewer financial resources, into a medical procedure with known and unknown risks, compromising the principle of informed consent.

The American Society for Reproductive Medicine (ASRM) has long provided guidelines on the matter, suggesting that financial compensation should be for a donor's time, inconvenience, and discomfort, and should not be so high as to become an undue enticement. While traditionally focused on cash payments, the principle extends to high-value services.

Furthermore, the long-term health impacts of ovarian stimulation and egg retrieval on donors are not fully understood, a fact that complicates the ability to give truly informed consent. Some studies have indicated that a significant percentage of past donors felt they were poorly informed about potential long-term health risks.

These programs also touch on the sensitive issue of gamete commodification—the idea of treating human eggs and sperm as products to be exchanged. While some see it as a pragmatic win-win, others worry it blurs the line between altruistic donation and a commercial transaction. For these programs to operate ethically, transparency about costs, risks, and success rates is paramount. Questions remain about the finer details of “no cost,” such as the duration of free storage and any potential financial liabilities for the donor if a cycle yields fewer eggs than expected. As this new frontier of fertility care expands, the industry's ability to balance market innovation with the welfare and autonomy of its donors will be its most critical test.